InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Jones John Philip, Chief Financial Officer. Officer active across 1 company, notably Alimera Sciences INC. In total, 10 disclosures have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €35k. Activity tracked since 30 April 2021. The latest transaction was filed on 31 October 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations10 total
372 shares@ US$4.4373.8% of flowCommon StockSEC:0001762007-22-000003:0
426 shares@ US$3.7573.6% of flowCommon StockSEC:0001474506-22-000038:0
8,750 shares0Common StockSEC:0001474506-22-000010
8,750 shares0Common StockSEC:0001474506-22-000010:0
5,000 shares@ US$4.079842.1% of flowCommon StockSEC:0001474506-21-000158:0
Ideal exit: 31 Jul 2022 (T+270)
5,000 shares@ US$4.079887.5% of flowCommon StockSEC:0001474506-21-000158
Ideal exit: 31 Jul 2022 (T+270)
399 shares@ US$3.7573.1% of flowCommon StockSEC:0001474506-21-000154:0
399 shares@ US$3.7573.0% of flowCommon StockSEC:0001474506-21-000154
421 shares@ US$3.56153.0% of flowCommon StockSEC:0001474506-21-000083
421 shares@ US$3.56153.0% of flowCommon StockSEC:0001474506-21-000083:0
10 of 10 declarations
About Jones John Philip
John Philip Jones is the Chief Financial Officer at ALIMERA SCIENCES INC. He is responsible for the financial management of the company, including financial planning and analysis. His role is crucial for ensuring financial health and supporting the company's growth.
